Agios Pharmaceuticals' IPO

Agios Pharmaceuticals raised a round of funding on July 24, 2013. Investors include Public.

Agios Pharmaceuticals is a biopharmaceutical company dedicated to the discovery and development of therapeutics in the field of cancer metabolism. To support and drive these efforts, Agios has built a…

Articles about Agios Pharmaceuticals' IPO: